These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

865 related items for PubMed ID: 18954096

  • 1. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
    Demirgöz D, Garg A, Kokkoli E.
    Langmuir; 2008 Dec 02; 24(23):13518-24. PubMed ID: 18954096
    [Abstract] [Full Text] [Related]

  • 2. Effect of linker and spacer on the design of a fibronectin-mimetic peptide evaluated via cell studies and AFM adhesion forces.
    Craig JA, Rexeisen EL, Mardilovich A, Shroff K, Kokkoli E.
    Langmuir; 2008 Sep 16; 24(18):10282-92. PubMed ID: 18693703
    [Abstract] [Full Text] [Related]

  • 3. PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.
    Shroff K, Kokkoli E.
    Langmuir; 2012 Mar 13; 28(10):4729-36. PubMed ID: 22268611
    [Abstract] [Full Text] [Related]

  • 4. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
    Garg A, Tisdale AW, Haidari E, Kokkoli E.
    Int J Pharm; 2009 Jan 21; 366(1-2):201-10. PubMed ID: 18835580
    [Abstract] [Full Text] [Related]

  • 5. Enhanced integrin mediated signaling and cell cycle progression on fibronectin mimetic peptide amphiphile monolayers.
    Shroff K, Pearce TR, Kokkoli E.
    Langmuir; 2012 Jan 24; 28(3):1858-65. PubMed ID: 22149259
    [Abstract] [Full Text] [Related]

  • 6. pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.
    Garg A, Kokkoli E.
    Curr Pharm Biotechnol; 2011 Aug 24; 12(8):1135-43. PubMed ID: 21470144
    [Abstract] [Full Text] [Related]

  • 7. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
    Hamano N, Negishi Y, Fujisawa A, Manandhar M, Sato H, Katagiri F, Nomizu M, Aramaki Y.
    Int J Pharm; 2012 May 30; 428(1-2):114-7. PubMed ID: 22421321
    [Abstract] [Full Text] [Related]

  • 8. Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.
    Messerschmidt SK, Musyanovych A, Altvater M, Scheurich P, Pfizenmaier K, Landfester K, Kontermann RE.
    J Control Release; 2009 Jul 01; 137(1):69-77. PubMed ID: 19306900
    [Abstract] [Full Text] [Related]

  • 9. Dual-ligand α5β1 and α6β4 integrin targeting enhances gene delivery and selectivity to cancer cells.
    Levine RM, Kokkoli E.
    J Control Release; 2017 Apr 10; 251():24-36. PubMed ID: 28215671
    [Abstract] [Full Text] [Related]

  • 10. Biomimetic peptide-amphiphiles for functional biomaterials: the role of GRGDSP and PHSRN.
    Mardilovich A, Kokkoli E.
    Biomacromolecules; 2004 Apr 10; 5(3):950-7. PubMed ID: 15132686
    [Abstract] [Full Text] [Related]

  • 11. Design of a novel fibronectin-mimetic peptide-amphiphile for functionalized biomaterials.
    Mardilovich A, Craig JA, McCammon MQ, Garg A, Kokkoli E.
    Langmuir; 2006 Mar 28; 22(7):3259-64. PubMed ID: 16548586
    [Abstract] [Full Text] [Related]

  • 12. Poly(ethylene glycol)-grafted liposomes with oligopeptide or oligosaccharide ligands appended to the termini of the polymer chains.
    Zalipsky S, Mullah N, Harding JA, Gittelman J, Guo L, DeFrees SA.
    Bioconjug Chem; 1997 Mar 28; 8(2):111-8. PubMed ID: 9095350
    [Abstract] [Full Text] [Related]

  • 13. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
    Jiang X, Sha X, Xin H, Chen L, Gao X, Wang X, Law K, Gu J, Chen Y, Jiang Y, Ren X, Ren Q, Fang X.
    Biomaterials; 2011 Dec 28; 32(35):9457-69. PubMed ID: 21911250
    [Abstract] [Full Text] [Related]

  • 14. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.
    Dai W, Yang T, Wang X, Wang J, Zhang X, Zhang Q.
    J Drug Target; 2010 May 28; 18(4):254-63. PubMed ID: 19824864
    [Abstract] [Full Text] [Related]

  • 15. Binding of the fibronectin-mimetic peptide, PR_b, to alpha5beta1 on pig islet cells increases fibronectin production and facilitates internalization of PR_b functionalized liposomes.
    Atchison NA, Fan W, Papas KK, Hering BJ, Tsapatsis M, Kokkoli E.
    Langmuir; 2010 Sep 07; 26(17):14081-8. PubMed ID: 20704278
    [Abstract] [Full Text] [Related]

  • 16. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD, Huang L.
    Mol Pharm; 2006 Sep 07; 3(5):579-88. PubMed ID: 17009857
    [Abstract] [Full Text] [Related]

  • 17. Ligand-based targeted delivery of a peptide modified nanocarrier to endothelial cells in adipose tissue.
    Hossen MN, Kajimoto K, Akita H, Hyodo M, Ishitsuka T, Harashima H.
    J Control Release; 2010 Oct 15; 147(2):261-8. PubMed ID: 20647023
    [Abstract] [Full Text] [Related]

  • 18. Pentapeptide YIGSR-mediated HT-1080 fibrosarcoma cells targeting of adriamycin encapsulated in sterically stabilized liposomes.
    Lopez-Barcons LA, Polo D, Reig F, Fabra A.
    J Biomed Mater Res A; 2004 Apr 01; 69(1):155-63. PubMed ID: 14999763
    [Abstract] [Full Text] [Related]

  • 19. Her2-targeted pegylated liposomal doxorubicin: retention of target-specific binding and cytotoxicity after in vivo passage.
    Shmeeda H, Tzemach D, Mak L, Gabizon A.
    J Control Release; 2009 Jun 05; 136(2):155-60. PubMed ID: 19331844
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.